Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Community weighted mean (CWM) of the three traits that we included in the measure of functional diversity for wood decomposing beetles captured around young (green) and veteran (br... by Ross Wetherbee (10326282)

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Changes in wavelet index, pain threshold index, mean arterial pressure and heart rate (mean ±SD) between two groups. by Guangquan An (11473126)

Capsaicin, pyridoxine, vincristine sulfate and ionomycin significantly decreased axon length ratio but only pyridoxine had no impact on neurotoxicity. by Fei San Lee (17282886)

“…(<b>C</b>) Pyr at 500 μM significantly decreased axon length ratio over time and was significantly lower than PBS control by day 3. …”

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Subjects:

Sodium levels in Canadian restaurant menu items compared to UK National Salt Reduction Initiative (NSRI) targets by UK NSRI food category. by Caroline G. Middleton (22041479)

Subjects:

Mean absolute change results of all clinical outcomes measured in diabetes related dyslipidemia. by Manik Chhabra (10822587)

Subjects:

Mean postoperative opioid quanities prescribed. by Nathan Coppersmith (18764685)

Participant characteristics (Mean ± SD) for each age group. by Markéta Rygelová (15453112)

Subjects:

Significant Decrease in Vessel Count of Trade Vessels in (a) Bosporus Strait and (b) Bab el-Mandeb Strait. by Cherryl Chico (20978829)

Associations between weight regain 5 years after RYGB and changes in PA outcomes. by Alice Bellicha (3583493)

Subjects:

Task variability/correlations decrease independently of mean task activity removal step in fMRI data. by Takuya Ito (57473)

An infographic outlining the data used for each analysis. by Shelby L. Sturrock (10751675)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Bar graphs showing the means and 95% CI of each retinal layer thickness at each visit. by Jung-Tae Kim (8997767)

Subjects:

Changes in body composition, physical fitness, habitual physical activity and nutritional status 5 years after RYGB. by Alice Bellicha (3583493)

Subjects: